@bioclouseau.bsky.social
Biotech/Pharma investor. Interested in Healthcare, Tech, anything science related.
Investors lose their appetite for the obesity trade www.ft.com/content/963e...
January 23, 2025 at 9:14 AM
Investors lose their appetite for the obesity trade www.ft.com/content/963e...
Reposted
$RHHBY Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate
$80m upfront, $1b in milestones
www.prnewswire.com/news-release...
$80m upfront, $1b in milestones
www.prnewswire.com/news-release...
Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
www.prnewswire.com
January 2, 2025 at 12:08 PM
$RHHBY Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate
$80m upfront, $1b in milestones
www.prnewswire.com/news-release...
$80m upfront, $1b in milestones
www.prnewswire.com/news-release...
Reposted
$NMRA Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
Fail
ir.neumoratx.com/news-release...
Fail
ir.neumoratx.com/news-release...
Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder | Neumora Therapeutics, Inc.
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placebo Navacaprant showed an effic...
ir.neumoratx.com
January 2, 2025 at 12:02 PM
$NMRA Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
Fail
ir.neumoratx.com/news-release...
Fail
ir.neumoratx.com/news-release...
Reposted
I'm covering today's FDA VRBPAC meeting discussing the safety of pediatric RSV vaccines. The FDA stated on the outset that the clinical holds announced earlier this week did NOT apply to candidates with live-attenuated RSV vax candidates. At least one company that spares: Sanofi.
December 12, 2024 at 3:02 PM
I'm covering today's FDA VRBPAC meeting discussing the safety of pediatric RSV vaccines. The FDA stated on the outset that the clinical holds announced earlier this week did NOT apply to candidates with live-attenuated RSV vax candidates. At least one company that spares: Sanofi.
Reposted
Moderna did not disclose clinical holds on its RSV infant vaccines and instead waited two months post-hold to announce development of one of the vaccines would be stopped endpts.com/cases-of-sev...
Cases of severe RSV in two Moderna vaccine candidates' trials raise questions about future
Ahead of an advisory committee meeting later this week, the FDA revealed that all studies for RSV vaccines in young children and infants are currently on hold, including two not previously disclosed b...
endpts.com
December 10, 2024 at 5:27 PM
Moderna did not disclose clinical holds on its RSV infant vaccines and instead waited two months post-hold to announce development of one of the vaccines would be stopped endpts.com/cases-of-sev...
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor www.cell.com/cell/abstrac...
December 11, 2024 at 11:53 AM
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor www.cell.com/cell/abstrac...
A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them? www.wsj.com/health/healt...
November 29, 2024 at 7:47 AM
A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them? www.wsj.com/health/healt...
Reposted
Phase II miss for Alector's TREM2 in Alzheimer's disease: investors.alector.com/news-release...
Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update | Alector
SOUTH SAN FRANCISCO, Calif. , Nov. 25, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering novel, genetically validated therapies for the treatment...
investors.alector.com
November 25, 2024 at 9:28 PM
Phase II miss for Alector's TREM2 in Alzheimer's disease: investors.alector.com/news-release...
Reposted
New: Officials will issue proposed rules today to cover weight-loss drugs like Ozempic for millions of patients on Medicare and Medicaid.
But.
It’s up to Trump’s admin whether to finalize the rules. And RFK Jr. is no fan of Ozempic.
www.washingtonpost.com/health/2024/...
But.
It’s up to Trump’s admin whether to finalize the rules. And RFK Jr. is no fan of Ozempic.
www.washingtonpost.com/health/2024/...
Medicare proposes covering weight-loss drugs, teeing up clash with RFK Jr.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden administration said.
www.washingtonpost.com
November 26, 2024 at 10:36 AM
New: Officials will issue proposed rules today to cover weight-loss drugs like Ozempic for millions of patients on Medicare and Medicaid.
But.
It’s up to Trump’s admin whether to finalize the rules. And RFK Jr. is no fan of Ozempic.
www.washingtonpost.com/health/2024/...
But.
It’s up to Trump’s admin whether to finalize the rules. And RFK Jr. is no fan of Ozempic.
www.washingtonpost.com/health/2024/...
November 18, 2024 at 3:52 PM
Reposted
Here's the release. www.businesswire.com/news/home/20...
Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neu
www.businesswire.com
November 18, 2024 at 12:32 PM
Here's the release. www.businesswire.com/news/home/20...
Reposted
Allowing RFK Jr to destroy public health in America with his batshit pseudoscience is nothing short of a profound national security threat — and needs to be framed as such.
October 31, 2024 at 7:04 AM
Allowing RFK Jr to destroy public health in America with his batshit pseudoscience is nothing short of a profound national security threat — and needs to be framed as such.
Reposted
Good morning #biosky! Another biotech launched by Paragon is going public via reverse merger. This time it's Jade Therapeutics, with an anti-APRIL mAb for IgA nephropathy, merging with Aerovate $AVTE. Fairmount, Venrock among leaders of $300m PIPE. www.globenewswire.com/news-release...
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement...
www.globenewswire.com
October 31, 2024 at 11:38 AM
Good morning #biosky! Another biotech launched by Paragon is going public via reverse merger. This time it's Jade Therapeutics, with an anti-APRIL mAb for IgA nephropathy, merging with Aerovate $AVTE. Fairmount, Venrock among leaders of $300m PIPE. www.globenewswire.com/news-release...
$RHHBY Roche Reveals Patient Death in Early Alzheimer’s Trial www.bloomberg.com/news/article...
Roche Reveals Patient Death in Early Alzheimer’s Trial
An elderly patient died in a clinical study of Roche Holding AG’s experimental treatment for Alzheimer’s disease, prompting changes to the trial design, although the company said overall results suppo...
www.bloomberg.com
October 30, 2024 at 9:14 AM
$RHHBY Roche Reveals Patient Death in Early Alzheimer’s Trial www.bloomberg.com/news/article...
Reposted
Politics raises its ugly head on the blog again. And man, is it ever ugly this time.
The Choice
www.science.org
October 29, 2024 at 6:36 PM
Politics raises its ugly head on the blog again. And man, is it ever ugly this time.